Pharmaceutical Technology on MSN
FDA backs generics onshoring push with ANDA priority scheme
Drug manufacturers who test and produce their generic medicines on US soil will now have access to priority review.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback